
Episode 18: Playground Global's Jory Bell
BioVenture VoiCes with Chris Garabedian
00:00
Tech‑bio vs. traditional biotech distinction
Jory contrasts focusing on enabling technologies versus novel biology, positioning Playground as tech‑bio investors.
Play episode from 01:10:10
Transcript


